Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;6(1):122-32.
doi: 10.2215/CJN.05750710. Epub 2010 Sep 28.

Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft

Affiliations

Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft

Samih H Nasr et al. Clin J Am Soc Nephrol. 2011 Jan.

Abstract

Background and objectives: Proliferative GN with monoclonal IgG deposits (PGNMID) is a newly described entity resembling immune complex GN. Its potential to recur in the allograft is undefined.

Design, setting, participants, & measurements: The first cases of recurrent PGNMID in the allograft are reported.

Results: The cohort includes four Caucasians (3 women, 1 man) with a mean age 58.5 years. No patient had M spike or hematologic malignancy. Recurrence was first documented by biopsy at a mean of 3.8 months posttransplant for indications of renal insufficiency in four patients, proteinuria in three patients, and microhematuria in three patients. Monoclonal IgG deposits (3 IgG3κ and 1 IgG3λ) in the transplants had identical heavy- and light-chain isotypes as in the native kidneys. In two patients, a pattern of endocapillary GN was identified in the native and transplant biopsies, whereas two patients with membranoproliferative GN in the native kidney developed endocapillary or mesangial GN in the transplant. Recurrence was treated with combined high-dose prednisone plus rituximab (n = 3) or plus cyclophosphamide (n = 1). After a mean posttransplant follow-up of 43 months, all four patients achieved reduction in proteinuria and three had reduction in creatinine. Repeat biopsies showed reduced histologic activity after treatment.

Conclusions: PGNMID can recur in the transplant despite the absence of a serum M spike. Recurrence is heralded by proteinuria, hematuria, and allograft dysfunction and manifests diverse histologic patterns. Although the pathogenesis remains unknown, early immunosuppressive therapy appears to stabilize the course.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
LM findings. (A) The third transplant biopsy in patient #1 showed diffuse endocapillary proliferative GN. The three glomeruli depicted in this representative image show global endocapillary hypercellularity. Small segmental cellular crescents are present in two glomeruli (arrows) (hematoxylin and eosin; ×200). (B) The fourth transplant biopsy performed after therapy showed less disease activity. The two glomeruli depicted show mesangial hypercellularity, one of which also exhibits minimal segmental endocapillary hypercellularity (hematoxylin and eosin; ×200).
Figure 2.
Figure 2.
This representative electron micrograph from the third transplant biopsy in patient #1 shows segmental granular subendothelial electron-dense deposits that range from small (small arrows) to large (large arrow). Minute paramesangial electron-dense deposits are also apparent (arrowhead). Podocytes exhibit marked foot process effacement (×4200).
Figure 3.
Figure 3.
The third transplant biopsy in patient #1 shows strong glomerular staining for kappa light chain with negative staining for lambda light chain (IF micrograph ×400).
Figure 4.
Figure 4.
IF staining for the IgG subtypes performed on the first transplant biopsy with recurrence in patient #3 shows intense glomerular positivity for IgG3 with negative staining for IgG1, IgG2, and IgG4 (×400).

References

    1. Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD: Renal monoclonal immunoglobulin deposition disease: The disease spectrum. J Am Soc Nephrol 12: 1482–1492, 2001 - PubMed
    1. Nasr SH, Colvin R, Markowitz GS: IgG1 lambda light and heavy chain renal amyloidosis. Kidney Int 70: 7, 2006 - PubMed
    1. Nasr SH, Markowitz GS, Reddy BS, Maesaka J, Swidler MA, D'Agati VD: Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int 69: 772–775, 2006 - PubMed
    1. Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD: Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int 63: 1450–1461, 2003 - PubMed
    1. Nasr SH, Markowitz GS, Stokes MB, Seshan SV, Valderrama E, Appel GB, Aucouturier P, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis. Kidney Int 65: 85–96, 2004 - PubMed

Substances